Optimum Investment Advisors’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-2
| Closed | -$204 | – | 733 |
|
|
2023
Q2 | $204 | Hold |
2
| – | – | ﹤0.01% | 691 |
|
|
2023
Q1 | $182 | Hold |
2
| – | – | ﹤0.01% | 718 |
|
|
2022
Q4 | $76 | Hold |
2
| – | – | ﹤0.01% | 750 |
|
|
2022
Q3 | $0 | Hold |
2
| – | – | ﹤0.01% | 886 |
|
|
2022
Q2 | $0 | Hold |
2
| – | – | ﹤0.01% | 889 |
|
|
2022
Q1 | $0 | Sell |
2
-616
| -100% | – | ﹤0.01% | 911 |
|
|
2021
Q4 | $16K | Hold |
618
| – | – | 0.01% | 624 |
|
|
2021
Q3 | $62K | Hold |
618
| – | – | 0.03% | 418 |
|
|
2021
Q2 | $87K | Sell |
618
-29
| -4% | -$4.08K | 0.03% | 410 |
|
|
2021
Q1 | $65K | Hold |
647
| – | – | 0.02% | 444 |
|
|
2020
Q4 | $80K | Sell |
647
-609
| -48% | -$75.3K | 0.02% | 399 |
|
|
2020
Q3 | $122K | Buy |
1,256
+522
| +71% | +$50.7K | 0.04% | 303 |
|
|
2020
Q2 | $115K | Hold |
734
| – | – | 0.04% | 303 |
|
|
2020
Q1 | $106K | Sell |
734
-273
| -27% | -$39.4K | 0.04% | 294 |
|
|
2019
Q4 | $206K | Buy |
1,007
+200
| +25% | +$40.9K | 0.06% | 266 |
|
|
2019
Q3 | $65K | Buy |
807
+2
| +0.2% | +$161 | 0.02% | 461 |
|
|
2019
Q2 | $76K | Buy |
+805
| New | +$76K | 0.02% | 429 |
|